产品封面图
文献支持

Anti-HAstV Capsid Protein Poly

clonal Antibody
收藏
  • ¥1668
  • abinScience
  • China
  • VK033014
  • 2025年07月25日
  • ELISA, IHC, WB
  • Rabbit
  • Human astrovirus-2, Human astrovirus-8, Human astrovirus-4, Human astrovirus-3, Human astrovirus-1, Human astrovirus-7
avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 免疫原

      Rabbit

    • 亚型

      IgG

    • 形态

      Liquid

    • 保存条件

      0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

    • 克隆性

      Polyclonal

    • 标记物

      Unconjugated

    • 适应物种

      Human astrovirus-2, Human astrovirus-8, Human astrovirus-4, Human astrovirus-3, Human astrovirus-1, Human astrovirus-7

    • 保质期

      1 year

    • 抗原来源

      Rabbit

    • 目录编号

      VK033014

    • 级别

      科研级别

    • 库存

      999

    • 供应商

      abinScience

    • 宿主

      Rabbit

    • 应用范围

      ELISA, IHC, WB

    • 浓度

      1mg/mL

    • 靶点

      capsid protein, ORF2

    • 抗体英文名

      Anti-HAstV Capsid Protein Polyclonal Antibody

    • 抗体名

      Anti-HAstV Capsid Protein Polyclonal Antibody

    • 规格

      100ul

    产品细节图片1

    Product nameAnti-HAstV Capsid Protein Polyclonal Antibody
    Catalog No.VK033014
    Host speciesRabbit
    Species reactivityHuman astrovirus-2, Human astrovirus-8, Human astrovirus-4, Human astrovirus-3, Human astrovirus-1, Human astrovirus-7
    ImmunogenE. coli - derived recombinant HAstV-2 Capsid polyprotein VP90 (Lys71-Leu411).
    FormLiquid
    Storage buffer0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
    Purity/
    ClonalityPolyclonal
    IsotypeIgG
    ApplicationsELISA, IHC, WB
    Targetcapsid protein, ORF2
    PurificationPurified by antigen affinity column.
    Endotoxin levelPlease contact with the lab for this information.
    Expression system/
    AccessionQ82446, Q9IFX1, Q3ZN05, Q9WFZ0, O12792, Q96818
    Alternative Names/
    Clone ID/
    Species/
    Product Usage InformationELISA:1:5000-1:20000;IHC:1:50-1:500;WB:1:500-1:2000

    abinScience, founded in 2023 in Strasbourg, France, is committed to developing and producing high-quality life science reagents. Rooted in one of Europe’s leading hubs for scientific innovation, abinScience empowers global research through reliable, efficient experimental solutions. Guided by the vision of “Empowering Bioscience Discovery,” we support scientists worldwide in advancing the frontiers of bioscience.

     

    Technology and Innovation

    Relying on the global leading position in antibody and protein research and more than 20 years of industry experience of its parent company ProteoGenix since 2003, abinScience has inherited advanced technologies and high-quality standards. In particular, the XtenCHO™ system developed by ProteoGenix, which has two modes of transient expression and stable expression, has been widely recognized as a core technology to improve the efficiency of protein production, providing a solid foundation for abinScience's product research and development.

     

    Product categories and application fields.

    Main products.
    10000+ high-activity proteins.
    15000+ antibody series products:
    Classic monoclonal antibody.
    Monoclonal antibody
    Internal control antibody, labeled antibody.
    High-quality phosphorylation antibodies.
    Highly specific nanobodies and small molecule antibodies.
    Functional antibodies in vivo.
    Low-background flow cytometry antibodies.
    DNA/RNA antibodies and PEG antibodies.
    1000+ reagent kit series products.
    Large-scale packaging customization services: We offer personalized antibody design, protein production, molecular optimization, and experimental development services.


    Application field

    Infectious disease research: including viruses, superbugs, parasites, etc.
    Neuroscience research: Supporting research on neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
    Immunology research: Covers the research needs of immune activation, inhibition, and allergies and abnormal reactions.
    Oncology research: Supporting the development of tumor biology and anti-tumor drugs.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    • Non-Assembled ORF2 Capsid Protein of Porcine Circovirus 2b Does Not Confer Protective Immunity., PMID:34578193
    • The Capsid (ORF2) Protein of Hepatitis E Virus in Feces Is C-Terminally Truncated., PMID:35055972
    • An Arginine-Rich Motif in the ORF2 capsid protein regulates the hepatitis E virus lifecycle and interactions with the host cell., PMID:36007070
    • The AP-1 adaptor complex is essential for intracellular trafficking of the ORF2 capsid protein and assembly of Hepatitis E virus., PMID:39117755
    • New insights into the ORF2 capsid protein, a key player of the hepatitis E virus lifecycle., PMID:31000788
    • Conservation and variation of the hepatitis E virus ORF2 capsid protein., PMID:30180962
    • Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid Protein., PMID:28958858
    • Expression and Immunogenicity of SARS-CoV-2 Virus-Like Particles based on Recombinant Truncated HEV-3 ORF2 Capsid Protein., PMID:36224764
    • Molecular characterization of chicken astrovirus from high embryonic mortality, based on the capsid protein (ORF2) gene, in Brazil., PMID:35791746
    • Expression and immunogenicity of hepatitis E virus-like particles based on recombinant truncated ORF2 capsid protein., PMID:36526214
    相关实验
    • Polyclonal Antibody Production

      , if desired this is best accomplished by Protein A Affinity Chromatography.   上一篇:make an Antibody against a Peptides   下一篇:Immunization Protocol for Monoclonal Antibody Production

    • Polyclonal Antibody Production

        Polyclonal Antibody Production Very useful for rapid and simple generation of antibodies for western blots, ELISA assays, and immunoprecipitation.     Rabbit Immunization Initial Preparation Your antigen

    • Human Anti-antibody Response

      on safety and efficacy. Therefore, assessment of immunogenicity of the therapeutic protein is an essential part of its clinical development. This involves testing strategies which provide relevant information on antibody responses. This chapter describes

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥857
    广州市左克生物科技发展有限公司
    2025年09月02日询价
    ¥1680
    上海圻明生物科技有限公司
    2025年12月22日询价
    ¥1668
    普健生物(武汉)科技有限公司
    2025年07月25日询价
    询价
    维百奥(北京)生物科技有限公司
    2026年01月07日询价
    ¥2000
    北京索莱宝科技有限公司
    2025年07月13日询价
    文献支持
    Anti-HAstV Capsid Protein Polyclonal Antibody
    ¥1668